Table 3.
1 month after surgery | 3 months after surgery | 6 months after surgery | p | p | |||
---|---|---|---|---|---|---|---|
2 and 1 | 3 and 1 | 3 and 2 | |||||
OSDI | 17.25 ± 4.48∗ | 14.51 ± 4.01∗ | 14.40 ± 4.15∗ | <0.001 | <0.001 | <0.001 | 0.818 |
SIT (mm) | 11.92 ± 4.31#† | 12.68 ± 3.68#† | 12.91 ± 3.31#† | 0.241 | 0.273 | 0.158 | 0.749 |
NIBUTav (s) | 9.04 ± 4.06∗ | 11.12 ± 4.12∗† | 11.14 ± 4.27∗† | <0.001 | <0.001 | <0.001 | 0.972 |
TMH (mm) | 0.23 ± 0.10#† | 0.23 ± 0.09#† | 0.23 ± 0.09#† | 0.882 | 0.846 | 0.967 | 0.815 |
Meiboscore | 2.86 ± 1.19# | 2.94 ± 1.05# | 2.79 ± 1.25# | 0.582 | 0.466 | 0.560 | 0.191 |
Eyelid margin abnormality | 1.10 ± 0.61∗† | 1.10 ± 0.59∗† | 1.10 ± 0.59∗† | <0.001 | 1.000 | 1.000 | 1.000 |
Lipid layer grading | 1.67 ± 0.99∗ | 2.00 ± 0.65∗† | 2.05 ± 0.71∗† | <0.001 | 0.005 | 0.001 | 0.684 |
p, significance level in Pearson's correlation analysis. Data are expressed as means ± SD. #Preoperative vs. postoperative comparison; p > 0.05. ∗Preoperative vs. postoperative comparison; p < 0.05. †Preoperative vs. control group comparison; p > 0.05.